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Netrin-1 was recently proposed to play an important
role in embryonic and pathological angiogenesis.
However, data reported led to the apparently contra-
dictory conclusions that netrin-1 is either a pro- or an
antiangiogenic factor. Here, we reconcile these
opposing observations by demonstrating that ne-
trin-1 acts as a survival factor for endothelial cells,
blocking the proapoptotic effect of the dependence
receptor UNC5B and its downstream death signaling
effector, the serine/threonine kinase DAPK. The
netrin-1 effect on blood vessel development is
mimicked by caspase inhibitors in ex vivo assays,
and the inhibition of caspase activity, the silencing
of the UNC5B receptor, and the silencing of DAPK
are each sufficient to rescue the vascular sprouting
defects induced by netrin-1 silencing in zebrafish.
Thus, the proapoptotic effect of unbound UNC5B
and the survival effect of netrin-1 on endothelial cells
finely tune the angiogenic process.
INTRODUCTION
Netrin-1, originally described as an axon guidance molecule, has
recently been shown to function in extraneural processes as well,
ranging from a role in branched organs morphogenesis to a func-
tion in angiogenesis (Cirulli and Yebra, 2007; Liu et al., 2004; Lu
et al., 2004; Wilson et al., 2006). Interestingly, conflicting results
were reported regarding the role of netrin-1 during angiogenesis.
However, two clear genetic results initially appeared to be at
odds: whereas Eichmann, Tessier-Lavigne, and colleagues
elegantly demonstrated that the genetic inactivation of UNC5B
in mice is associated with increased angiogenesis, thereby sug-
gesting an antiangiogenic activity of netrin-1, Li and colleagues
showed that the inactivation of netrin-1a, which encodes a ligand
for UNC5B, is associated with a loss of vessels during zebrafish
development (Lu et al., 2004; Wilson et al., 2006).
We investigated here the possibility that these two apparently
contradictory observations could be explained by the ability of
netrin-1 to block apoptosis that would otherwise be induced614 Developmental Cell 16, 614–620, April 21, 2009 ª2009 Elsevier Iby its unbound UNC5B receptor, thus promoting survival of
endothelial cells during angiogenesis. Indeed, netrin-1 prevents
epithelial cell death by acting as a ligand for the dependence
receptors DCC and UNC5A–D, which share the functional prop-
erty that they are active both in the presence and in the absence
of their trophic ligands: whereas ligand binding triggers positive
signaling, dependence receptors induce a separate and distinct
signaling cascade, leading to cell death when disengaged from
their trophic ligands (Llambi et al., 2001; Mehlen et al., 1998;
Tanikawa et al., 2003; Bredesen et al., 2005; Mehlen and Brede-
sen, 2004). In this scheme, the loss of UNC5B—i.e., loss of proa-
poptotic signaling—would indeed be associated with an
increased number of blood vessels (Lu et al., 2004). On the
contrary, loss of netrin-1—i.e., increase of proapoptotic
signaling—is expected to be associated with the disappearance
of vessels (Wilson et al., 2006). Such a dynamic balance between
endothelial cell survival and apoptosis could help to maintain
blood vessel integrity, which is, in turn essential for vascular
homeostasis, both during vascular development and patholog-
ical angiogenesis, as previously described (Alavi et al., 2003;
Carmeliet, 2005; Duval et al., 2003; Santoro et al., 2007; Winn
and Harlan, 2005). Thus, the initially contradictory results of Eich-
mann et al. and Li et al. are readily resolved by the dependence
receptor hypothesis, and indeed provide further in vivo support
for this hypothesis.
RESULTS
Netrin-1 Blocks Endothelial Cell Apoptosis Induced
by Its Unbound UNC5B Receptor
To determine whether netrin-1 blocks apoptosis induced by its
unbound UNCB receptor, we first determined which netrin-1
dependence receptors are expressed in human umbilical vein/
artery endothelial cells (HUVECs/HUAECs). As revealed by
quantitative RT-PCR, UNC5A and UNC5B are both expressed
in HUVECs and HUAECs (Figure 1A), whereas we failed to detect
UNC5C, UNC5D, and DCC (data not shown). Netrin-1 was not
expressed in these cells, either at the RNA (Figure 1A) or protein
level (see Figures S1A and S1B available online). We then inves-
tigated whether netrin-1 behaves as a survival factor for endo-
thelial cells by analyzing its ability to block the spontaneous
propensity of HUVECs and HUAECs to undergo cell death under
serum starvation. Netrin was used at 50 ng/ml in all in vitronc.
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Apoptosis, Probably via Inhibition of
UNC5B-Induced Apoptosis
(A) Human umbilical vein/artery endothelial cells
(HUVECs/HUAECs) express UNC5A and UNC5B
dependence receptors, but not netrin-1. Quantita-
tive RT-PCRs were performed as described in
Experimental Procedures.
(B) Netrin-1 treatment inhibits HUVEC/HUAEC
death observed upon serum starvation, as
measured by trypan blue exclusion. At least
100 cells per condition were counted. The relative
index is shown as the mean ± SEM (n = 3). *,
p value < 0.005; **, p value < 0.0001 (Student’s t
test).
(C) Netrin-1 prevents apoptosis in HUVECs, as
measured by TUNEL staining. Quantification of
TUNEL-positive cells is mean ± SEM (Student’s t
test).
(D and E) Netrin-1 treatment reduces caspase-3
activity in HUVECs and HUAECs. Relative index
of caspase-3 activity is expressed as the mean ±
SEM (n = 3). Immunostaining and the relative index
(mean ± SEM) of cleaved caspase-3-positive cells
are shown (Student’s t test).
(F) UNC5B, but not UNC5A, silencing by siRNA is
associated with a decrease in caspase-3 activity.
Values are means and SEM (n = 3). All p < 0.05
(Student’s t test; compared to the level in the
control condition).
(G) DAP kinase mediates UNC5B-induced
apoptosis in HUVECs and HUAECs. Cell death
(Toxilight) in endothelial cells after forced expres-
sion of DAP kinase DCaM (the constitutively active
mutant form of DAP kinase) and of the DAP kinase
Death Domain (the dominant-negative form of
DAP kinase). Values are means and SEMs. All
p < 0.001 (Student’s t test; compared to the level
in the control condition).
(H) Netrin-1 treatment induces DAP kinase phos-
phorylation. Anti-phospho-DAP kinase was used
to determine the level of enzyme activity.experiments because this dose was previously described to be
physiological and functional (Serafini et al., 1994, 1996)
(Figure S1C). As shown in Figure 1B, netrin-1 inhibited both
HUVEC and HUAEC death (p < 0.005). Similar results were ob-
tained for etoposide-induced cell death (Figure S1D). Netrin-1
prevented endothelial cell apoptosis, as shown by the
decreased number of TUNEL-positive cells (Figure 1C) and by
the reduced caspase-3 activity (Figures 1D and 1E) (up to 30%
for HUVECs and 40% for HUAECs; all p < 0.005). The addition
of a recombinant protein corresponding to the extracellular
domain of UNC5H2 prevented netrin-1-mediated cell death inhi-
bition, supporting the conclusion that the survival effect is
specific for netrin-1 (Figure S1E). Thus, netrin-1 behaves as a
survival factor for endothelial cells.
To determine whether UNC5B and/or UNC5A induce
apoptosis in endothelial cells, we transiently silenced their
expression by using a siRNA strategy (Figure 1F; Figures S1FDevand S1G). UNC5B silencing led to a decreased caspase-3
activity, whereas UNC5A siRNA had no effect on caspase-3
activity (Figure 1F; all p < 0.05). Moreover, the addition of ne-
trin-1 together with UNC5B silencing was not associated with
an additional survival effect (Figure 1F). Thus, the netrin-1
survival effect on endothelial cells depends on UNC5B expres-
sion and likely results from an inhibition of apoptosis that would
otherwise be triggered by unbound UNC5B. Because UNC5B-
induced apoptosis has been shown to be mediated by DAP
kinase, we first expressed the constitutively active DAP kinase,
DAPK DCaM (Shohat et al., 2001), in HUVECs and HUAECs.
As shown in Figure 1G, expression of DAPK DCaM led to
increased cell death (all p < 0.0001). We next forced expression
of the dominant-negative mutant of DAP kinase, DAPK DD
(Llambi et al., 2005). Similarly to netrin-1 treatment, DAPK DD
prevented cell death induction. Moreover, because UNC5B
proapoptotic signaling is mediated by the activation of DAPelopmental Cell 16, 614–620, April 21, 2009 ª2009 Elsevier Inc. 615
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(Llambi et al., 2005), we next measured the DAP kinase phos-
phorylation level. As shown in Figure 1H, netrin-1 treatment led
to an increase in DAP kinase phosphorylation in HUVECs,
presumably by blocking the UNC5B proapoptotic signaling
cascade. Together with the observed increase in the number
of blood vessels in UNC5B mutant embryos (Lu et al., 2004),
these in vitro data support the view that netrin-1 is capable of
blocking UNC5B-induced apoptosis during angiogenesis.
The Netrin-1 Proangiogenic Effect Is Mimicked
by Caspase Inhibition and by Silencing of UNC5B
We next challenged the notion that the proangiogenic activity of
netrin-1 is related to its ability to promote cell survival, by using
Figure 2. Caspase Inhibitors and UNC5B
Silencing Mimic Netrin-1’s Effect on Neo-
vessel Formation
(A and B) The netrin-1 or caspase inhibitors z-VAD-
fmk and BAF promote microvessel formation in an
ex vivo murine aortic ring matrigel assay. Aortic
rings resected from at least eight different mice
are shown per condition. Quantification of micro-
vessel total length (pixels units) was performed
as described in Experimental Procedures. All
p values are indicated (c2 test).
(C and D) Netrin-1 and caspase inhibitors induce
neovessel formation in a CAM assay. CAM
models were prepared by using 8-day-old chick
embryos treated as described in Experimental
Procedures (n R 10). Methylcellulose disks are
outlined. De novo angiogenesis is expressed as
the number of branching points (n R 13 fields
per condition). Means are indicated by straight
lines. *, p value < 0.02; **, p value < 0.0005
(Mann-Whitney U-test).
(E and F) UNC5B silencing by siRNA leads to an
increase in neovessel formation in a CAM assay.
Three siRNA injections were performed between
E.5 and E.9, as described in Experimental Proce-
dures. Scramble siRNA was used as a control.
De novo angiogenesis is expressed as the
number of branching points (n > 30 different
fields per condition). Means are indicated by
straight lines. p value = 0.009 (Mann-Whitney
U-test).
ex vivo models of neoangiogenesis. We
first used a mouse aortic ring assay and
assessed the expression of UNC5H2,
the murine ortholog of UNC5B, in the
aortic explants (Figure S2A). Netrin-1
was not found to be expressed in the
explants (data not shown). Similarly to
what has been observed with VEGF, ne-
trin-1 treatment enhanced capillaries
sprouting from matrigel-embedded aortic
rings, in comparison to control conditions
(Figures 2A and 2B; p < 0.001), supporting
a proangiogenic activity of netrin-1. Inter-
estingly, caspase inhibitors z-VAD-fmk
and BAF also induced neocapillary tube formation, mimicking
the effect of netrin-1 (Figures 2A and 2B; p < 0.002). Identical
results were obtained in the chick-chorioallantoic membrane
(CAM) assay (Figures 2C and 2D; Figure S2B for expression
analysis). Indeed, we observed a significant increase in neoves-
sel formation in the vicinity of methylcellulose discs soaked
either with VEGF, netrin-1, z-VAD-fmk, or BAF (Figures 2C
and 2D; p < 0.02). Thus, in these ex vivo physiological models,
inhibition of apoptosis appears to be sufficient to mimic the
effects of netrin-1. Moreover, UNC5B silencing by siRNA in
CAM (Figure S2C) led to an increase in neovessel ramifications,
demonstrating that netrin-1 and its receptor, UNC5B, act in an
antagonistic manner during the angiogenic process (Figures 2E
and 2F; p = 0.009).616 Developmental Cell 16, 614–620, April 21, 2009 ª2009 Elsevier Inc.
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Leads to Vascular Defects that Are Rescued by Caspase
Inhibition and by UNC5B/DAP Kinase Silencing
To further explore in vivo the cause-and-effect relationship
between the proangiogenic and the antiapoptotic activities of
netrin-1, we investigated whether antiapoptotic treatment could
rescue vessel defects induced by netrin-1 disruption during ze-
brafish development. Two netrin-1 gene orthologs have been
characterized in zebrafish, netrin-1a and netrin-1b (Lauderdale
et al., 1997; Strahle et al., 1997). Whereas netrin-1b silencing
had no obvious effect on vessel development (Figure S3A), both
Eichman’s group and Li’s group have shown, by using different
netrin-1a morpholinos, that silencing of netrin-1a is associated
with vessel development defects (Lu et al., 2004; Wilson et al.,
2006). Netrin-1a silencing with a splice-blocking morpholino
(spl-netrin-1a) has been shown to prevent the formation of para-
chordal vessels (PAVs) (Wilson et al., 2006). Using fli:egfp trans-
genic zebrafish—a transgenic model targeting the expression of
GFP specifically in blood vessels (Lawson and Weinstein,
2002)—we indeed observed at 50–54 hr postfertilization (hpf)
that 57.3% of the embryos injected with such spl-netrin-1a mor-
pholinos lacked PAVs (n = 75), whereas the development of inter-
segmental vessels (ISVs) and dorsal longitudinal anastomotic
Figure 3. Phenotype of Knockdown netrin-
1a Zebrafish Embryos Is Rescued by Inhibi-
tion of Apoptosis
(A–C) fli:egfp zebrafish embryos were injected at
the one- to four-cell stage with control (ctl), splice
(spl), or translation (tsl)-blocking netrin-1a,
UNC5B, and DAP kinase morpholinos, alone or
in combination. Phenotypes were analyzed from
24 to 54 hours postfertilization. Representative
images of trunk vasculature are shown. Anterior
is oriented toward the left. (A and B) The caspase
inhibitor BAF restores parachordal vessel forma-
tion (asterisks) in (A) zebrafish embryos injected
with spl-blocking netrin-1a morpholinos and inter-
segmental vessel formation in (B) zebrafish
embryos injected with netrin-1a tsl morpholinos.
(B) Similar phenotypical rescue was observed by
simultaneous injection of UNC5B or DAP kinase
and tsl-blocking netrin-1amorpholinos in zebrafish
embryos. (A and B) Quantification is presented;
p values are indicated (c2 test). (C) BAF treatment
or injection ofUNC5B-blocking morpholinos inhibit
the increase in apoptosis observed after injection
of tsl-blocking netrin-1a morpholinos in zebrafish
embryos, as shown by TUNEL staining (left panels)
or caspase-3 activity (right panel). Caspase-3
activity is expressed as a relative index referred
to embryos injected with netrin-1a tsl morpholinos
solely. Means and SEM are calculated from three
independent experiments; p values are indicated
(Student t’s test).
vessels (DLAVs) was normal (Figure 3A).
Treatment of the spl-netrin-1a-injected
embryos with the pan-caspase inhibitor
BAF successfully reversed thisphenotype,
since PAV formation occurred in 92.6% of
treated embryos (n = 54) compared to
42.7% of untreated ones (Figure 3A; p < 0.0001). As described
previously (Wilson et al., 2006; Lu et al., 2004), we observed that
netrin-1a silencing with a translation-blocking morpholino (tsl-
netrin-1a, Figure S3B), as well as a third netrin-1a blocking mor-
pholino (Figure S3C), led to the disorganization of ISVs, to the
absence of the DLAV (Figure 3B), and also to developmental
defects. Time-lapse analysis of developing ISVs confirmed the
absence or premature arrest of ISVs (Movie S1). Similar defects
were previously described in zebrafish embryos knocked down
for the small inhibitor of apoptosis, the protein survivin (Ma et al.,
2007). Moreover, an increase in caspase-3 activity was observed
in netrin-1a knockdown embryos (Figure S3D). Treatment of these
embryos with BAF was sufficient to rescue ISV formation, since
54.5% of treated embryos displayed at least partial ISVs
compared to 23.0% of controls (Figure 3B; p < 0.001). In agree-
mentwith the dependence receptornotion, simultaneous injection
of UNC5B morpholinos (Figure S3B) was also able to correct the
defects induced by tsl-netrin-1a morpholino injection in 79.6%
of the embryos (n = 54) (Figure 3B; p < 0.0001). Similar rescue
was obtained by coinjecting tsl-netrin-1a morpholinos and mor-
pholinos targeting dap kinase (Figure 3B; p < 0.0001).
BAF treatment and UNC5B morpholino injection both rescued
the increase of cell death observed in embryos after netrin-1aDevelopmental Cell 16, 614–620, April 21, 2009 ª2009 Elsevier Inc. 617
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a caspase-3 activity assay (Figure 3C), hence providing further
support for the idea that the endothelial cell death inhibited by
netrin-1a is specifically mediated by UNC5B during vessel devel-
opment.
DISCUSSION
We have shown here that netrin-1 controls the survival of
endothelial cells and promotes angiogenesis, at least in part by
blocking apoptosis induced by its unbound UNC5B receptor.
Deregulation of this function could explain the modulation of
blood vessel formation that we and others have observed (Lu
et al., 2004; Wilson et al., 2006). This is in agreement with
growing lines of evidence describing the importance of cell death
regulation during developmental and pathological angiogenesis
(Birdsey et al., 2008; O’Connor et al., 2000; Santoro et al., 2007).
Based on the analysis of netrin-1 and UNC5B knockout animal
model phenotypes, contradictory conclusions that netrin-1 is
either pro- and antiangiogenic were previously reported (Lu
et al., 2004; Wilson et al., 2006). Despite additional discrepancies
between the various published studies to date (Larrivee et al.,
2007; Bouvree et al., 2008; Navankasattusas et al., 2008) that
emphasize the complexity of the netrin-1/UNC5B role in angio-
genesis (which, in and of themselves, might have resulted from
the use of different sources and concentrations of netrin-1
[Yang et al., 2007]), the dependence receptor model proposed
here in light of our results indicates that netrin-1 and UNC5B
function in an antagonistic manner during angiogenesis and
allows for a reconciliation of the apparently opposite genetic
observations obtained so far by the Eichmann and Li groups.
Even though other effects of netrin-1 on endothelial cells cannot
be ruled out—i.e., previously reported netrin-1 effects on in vitro
proliferation and migration of endothelial cells (Nguyen and Cai,
2006; Wilson et al., 2006; Park et al., 2004)—these effects prob-
ably do not contribute fully to the biological role of netrin-1 during
PAV or ISV development, since the inhibition of apoptosis was
sufficient to restore adequate vessel development.
Netrin-1 dependence receptors were recently proposed to act
as tumor suppressors by inducing apoptosis of epithelial cells
that would otherwise develop in settings of trophic ligand
unavailability (Grady, 2007; Mehlen and Puisieux, 2006). Loss
of the proapoptotic activity of its dependence receptors there-
fore represents a selective advantage for a tumor cell, as exem-
plified by the frequent loss of DCC and UNC5C expression in
colorectal cancer (Bernet et al., 2007; Mazelin et al., 2004).
Complementarily, gain of netrin-1 expression represents a similar
selective advantage for tumor cells, and this phenomenon is
indeed observed in some types of aggressive cancers, such as
metastatic breast cancers and lung cancer (Delloye-Bourgeois
et al., 2009; Fitamant et al., 2008). In light of the results presented
here, we propose that this autocrine netrin-1 gain of expression
in tumor epithelial cells may have two additive effects. First, as
reported, it confers a selective advantage for epithelial tumor
cells by inhibiting dependence receptor-induced cell death
(Fitamant et al., 2008). Second, it could also potentially favor
blood vessel maintenance and/or development, and could
consequently promote cancer progression. Therefore, an anti-
cancer approach based on disruption of netrin-1 function, by618 Developmental Cell 16, 614–620, April 21, 2009 ª2009 Elseviertitration or inhibition of the interaction with its receptors, should
eradicate not only tumor epithelial cells but also tumor angio-
genic vessels, thus further strengthening the position of netrin-1
as a critical target in cancer.
EXPERIMENTAL PROCEDURES
Endothelial Cell Culture and Transfection
Human umbilical vein and artery cells were cultured according to manufac-
turer’s instructions (Promocell, passages < 8) and were transfected by using
the AMAXA Nucleofector system. UNC5A, UNC5B, and scramble siRNAs
were designed by Sigma-Proligo. Plasmids encoding mutant DAP kinase
(DAPK DCam and DAPK DD) were described previously (Llambi et al., 2005).
Cell Death Assays
Cell death assays (Trypan blue, TUNEL immunostaining, caspase-3 activity)
were performed as described previously (Llambi et al., 2005; Tauszig-Delam-
asure et al., 2007; please also see Supplemental Experimental Procedures).
Netrin-1 was purchased from Axxora-Apotech. For the netrin-1 titration exper-
iment, rat recombinant UNC5H2-Fc (R&D) was used at 1 mg/ml.
Western Blot Analysis and Immunofluorescence
Protein extracts from endothelial cells were immunoblotted with anti-DAP
kinase and anti-phospho-DAP kinase antibodies (Sigma). For immunofluores-
cence analysis, anti-netrin-1 rat monoclonal antibody (R&D) was used at 1/150
dilution and was revealed by using a specific secondary antibody (Alexa 488
donkey anti-rat, Molecular Probes-Invitrogen).
Quantitative RT-PCR
Total RNA were extracted by using the Nucleospin RNAII kit (Macherey-Nagel),
and 1 mg was reverse transcribed by using the iScript cDNA Synthesis kit
(BioRad). Real-time quantitative RT-PCR was performed on a LightCycler
2.0 apparatus (Roche) by using the Light Cycler FastStart DNA Master
SYBERGreen I kit (Roche). Reaction conditions for all optimal amplification,
as well as primer selection, were determined as already described. The
sequences of the primers are available upon request.
Aortic Ring Assay
Aortic ring assays were performed as described by Nicosia and Ottinetti
(1990). Aortic rings resected from Balb/C mice of 6 to 8 weeks of age were
treated or not with netrin-1 (150 ng/ml), z-VAD-fmk (Tebu; 20 nM), BAF (Sigma;
20 nM), or VEGF (Sigma; 13 ng/ml) and photographed with a phase-contrast
microscope on day 4. Microvessel outgrowth total length was calculated by
using AxioVision Release 4.6 software.
CAM Assay
The chick chorioallantoic membrane (CAM) assay was performed as already
described. Netrin-1 (150 ng/ml), z-VAD-fmk (Tebu; 20 nM), BAF (Sigma;
20 nM), VEGF (Sigma), or control vehicles were diluted in 1% autoclaved meth-
ylcellulose solution. The methylcellulose disks obtained were placed on a CAM
of 8-day-old chick embryos. After 3 days, CAMs were photographed and the
angiogenic response was evaluated by measuring the number of secondary
ectopic vessel sprouts under the methylcellulose disks by using AxioVision
Release 4.6 software. UNC5B silencing in CAM was achieved by injection of
specific siRNA designed by Sigma-Proligo in CAM blood circulation at E.5,
E.7, and E.9. Analysis was performed at E.11.
Morpholino Knockdown of Zebrafish Embryos
A total of 6 ng splice/translation-blocking netrin-1a, UNC5B, and control mor-
pholinos that were previously designed and characterized were injected alone
or in combination in the high yolk of one- to four-cell-stage transgenic fli:egfp
zebrafish embryos. A third splice-blocking morpholino specifically targeting
netrin-1a and a translation-blocking morpholino targeting the zebrafish ortho-
log of DAP kinase were designed (GeneTools) and injected in embryos at 6 ng
and 3 ng, respectively. Sequences of morpholinos are available upon request.
Rescue of the phenotype induced by netrin-1a silencing was tested by adding
40 nM BAF in the E3 medium 4 hr after morpholino injection. TUNEL labeling ofInc.
Developmental Cell
Netrin-1 Survival Activity Controls Angiogenesisembryos was achieved as stated in Supplemental Experimental Procedures
and revealed by using Cy3-coupled streptavidine (1/400; Jackson Immunore-
search). A caspase-3 activity assay was performed as described above on
whole embryos at 24 hr of development. For time-lapse experiments, zebrafish
embryos were embedded in a 3% methylcellulose solution with 0.016% tri-
caine to inhibit movements (Isogai et al., 2003). Transmission videomicro-
scopic imaging was performed by using a Timelapse Axiovert100M (PLATIM,
ENS Lyon).
SUPPLEMENTAL DATA
Supplemental Data include three figures, two movies, and Supplemental
Experimental Procedures and can be found with this article online at http://
www.cell.com/developmental-cell/supplemental/S1534-5807(09)00079-3.
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